12-128415272-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136103.3(TMEM132C):c.626C>T(p.Thr209Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000238 in 1,597,782 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136103.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM132C | NM_001136103.3 | c.626C>T | p.Thr209Met | missense_variant | 2/9 | ENST00000435159.3 | |
TMEM132C | NM_001387058.1 | c.566C>T | p.Thr189Met | missense_variant | 2/9 | ||
TMEM132C | XM_047429886.1 | c.626C>T | p.Thr209Met | missense_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM132C | ENST00000435159.3 | c.626C>T | p.Thr209Met | missense_variant | 2/9 | 5 | NM_001136103.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151966Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000732 AC: 16AN: 218598Hom.: 0 AF XY: 0.0000843 AC XY: 10AN XY: 118602
GnomAD4 exome AF: 0.0000249 AC: 36AN: 1445816Hom.: 1 Cov.: 37 AF XY: 0.0000237 AC XY: 17AN XY: 717858
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151966Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74218
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.626C>T (p.T209M) alteration is located in exon 2 (coding exon 2) of the TMEM132C gene. This alteration results from a C to T substitution at nucleotide position 626, causing the threonine (T) at amino acid position 209 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at